Why San Diego Is A Growing Hub For RNA R&D And Drug Development

Editor’s note: Arcturus CEO Joe Payne is set to give a company presentation Wednesday at the BIO 2014 convention in San Diego. —BVB

Medicinal chemistry has come a long way since the first opiates were “prescribed” in 3500 B.C. Since then, we have seen advancements of science usher in over 1,100 FDA-approved drugs—with a substantial number of additional breakthroughs on the horizon. We now are witnessing the chemical development of three major classes of drugs: Small molecules; Antibodies; (and more recently) RNA therapeutics.